Chindex International said Fosun Pharmaceutical has purchased 933,022 of its shares at $15 per share. The investment is part of a previously announced transaction that will establish a medical device JV between the two companies. Chindex is spinning off its medical device manufacturing and distribution business into the JV, which will be owned 51% by Fosun.  More details....

Stock Symbols: (NSDQ: CHDX)  (SHEX: 600196)